U.S. Markets open in 9 hrs 8 mins

Neuren Pharmaceuticals Limited (NEU.AX)


ASX - ASX Delayed Price. Currency in AUD
Add to watchlist
0.059-0.002 (-3.279%)
As of 1:36PM AEST. Market open.
Currency in AUD

Valuation Measures

Market Cap (intraday) 5109.38M
Enterprise Value 3N/A
Trailing P/E -8.43
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)83.75
Price/Book (mrq)29.50
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6N/A

Financial Highlights

Fiscal Year
Fiscal Year Ends Dec 31, 2016
Most Recent Quarter (mrq)Dec 31, 2016
Profitability
Profit Margin 0.00%
Operating Margin (ttm)-1,061.33%
Management Effectiveness
Return on Assets (ttm)-74.96%
Return on Equity (ttm)-129.29%
Income Statement
Revenue (ttm)1.31M
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)1,775.40%
Gross Profit (ttm)-11M
EBITDA -13.78M
Net Income Avi to Common (ttm)-12.01M
Diluted EPS (ttm)-0.01
Quarterly Earnings Growth (yoy)N/A
Balance Sheet
Total Cash (mrq)5.05M
Total Cash Per Share (mrq)0
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)2.99
Book Value Per Share (mrq)0.00
Cash Flow Statement
Operating Cash Flow (ttm)-12.38M
Levered Free Cash Flow (ttm)-9.15M

Trading Information

Stock Price History
Beta -1.26
52-Week Change 30.00%
S&P500 52-Week Change 314.06%
52 Week High 30.094
52 Week Low 30.041
50-Day Moving Average 30.063
200-Day Moving Average 30.069
Share Statistics
Avg Vol (3 month) 31.05M
Avg Vol (10 day) 31.1M
Shares Outstanding 51.85B
Float 1.1B
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short 3N/A
Short Ratio 3N/A
Short % of Float 3N/A
Shares Short (prior month) 3N/A
Dividends & Splits
Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A